INTRODUCTION
============

Guided developmental cell migrations require complex signal integration and regulation of actin and microtubule cytoskeletons to provide dynamic cell infrastructure and communication in a three-dimensional setting ([@B38]; [@B58]; [@B54]; [@B57]; [@B17]). *Drosophila* hemocytes (macrophages) provide an excellent in vivo cell migration model, as they undergo characteristic developmental migrations, as well as chemotactic migrations toward wounds or pathogen invasion ([@B50]; [@B48]; [@B53]; [@B54]; [@B42]). Hemocytes are highly polarized and exhibit exuberant actin-rich cellular protrusions ([Figure 1A](#F1){ref-type="fig"}). Hemocytes originate in the head mesoderm at stage 10 and undergo four major stereotypical developmental migrations ([Figure 1B](#F1){ref-type="fig"}). 1) A subset of hemocytes leave the head mesoderm in stage 10 embryos and travel to the posterior tail region through an invasive epithelial transmigration. 2) In stage 12--14 embryos, the hemocytes remaining in the head region migrate posteriorly along the ventral midline and dorsal vessel. 3) Also in stage 12--14 embryos, tail hemocytes (the transmigrated hemocytes that are now at the posterior end of embryo after germ-band retraction) move anteriorly along the ventral midline. 4) During stage 14, hemocytes migrating toward each other from the anterior and posterior ends of the embryo along the ventral midline converge and then undergo lateral migrations from the midline to form three parallel lines of circulating cells. Platelet-derived growth factor/vascular endothelial growth factor--receptor-related (PVR) signaling has been proposed to control these hemocyte developmental migrations ([@B53]). The PVR ligands Pvf2 and Pvf3 are expressed in the embryonic ventral midline beginning at stages 10 and 12, respectively, where they are proposed to drive head and tail hemocyte migration before being reduced before lateral hemocyte migration during stage 14 ([@B53]). Recent studies, however, show that Pvf2 and Pvf3 only contribute to the first transmigration step, where they coordinate invasion through the head and tail epithelial barriers ([@B32]). This transmigration step has been shown to involve RhoL, a Rho-family GTPase that is expressed specifically in hemocytes, which regulates invasion, adhesion, and Rap1 localization ([@B42]).

![Rho1 participates in a subset of hemocyte developmental migrations. (A) Confocal surface projection micrograph of an otherwise wild-type hemocyte expressing the Actin5C-GFP reporter. (B) Schematic of *Drosophila* hemocyte developmental migrations in stage 10--16 embryos from lateral or ventral perspectives. The major events indicated are 1) transmigration of hemocytes from the head to the tail, 2) posterior migration of head hemocytes along ventral midline, 3) anterior migration of tail hemocytes along ventral midline, and 4) lateral migration of hemocytes from the ventral midline to form three parallel lines. Head and tail are indicated. A, anterior; P, posterior; D, dorsal; V, ventral. (C) Confocal surface projection micrograph of an otherwise wild-type hemocyte expressing a Rho1 biosensor (*UAS-Pkn^RBD^-GFP*) under the control of the Pxn-Gal4 driver. (D) Western analysis of protein extracts from control (*Pxn-Gal4*) and *Rho1^RNAi^* hemocytes probed with antibodies recognizing Rho1 (α-Rho1(P1D9)) and a loading control (α-Gro). The normalized levels of Rho1 are indicated (with control set to 100). (E--G′) Time-lapse series of surface projections (ventral view) of migrating hemocytes expressing GFP in control (*Pxn-Gal4*) (E), *Rho1^1B^* (F), and *Rho1^RNAi^* (G) embryos. Head and tail are indicated (E). Hemocytes that began their developmental migrations in the tail were tracked for 180 min (E′, F′, G′). Note that all of the tail hemocytes present in G arrived from the anterior. (H, I) Quantification of the number of transmigrated tail hemocytes (H) and number of these tail hemocytes that migrate anteriorly (I) in control (*Pxn-Gal4*), *Rho1^1B^*, and *Rho1^RNAi^* embryos (*n* ≥ 20). (J--L) Confocal surface projection (lateral view) micrographs of stage 10 control (*Pxn-Gal4)* (J), *Rho1^1B^* (K), and *Rho1^RNAi^* (L) embryos stained for DE-cadherin (red) and GFP (green). Transmigrated hemocytes are circled. All results are given as means ± SEM; *p* values are indicated. Scale bars, 10 μm (A, C), 40 μm (E--G′, J--L).](1665fig1){#F1}

Hemocyte migration in response to developmental or chemotactic stimuli is initiated through polarized dynamic membrane protrusions and endocytosis. The driving force for these membrane protrusions is localized polymerization of cortical actin filaments ([@B38]; [@B49]; [@B17]). One family of proteins that mediate membrane--cortical cytoskeleton interactions, as well as vesicle trafficking, is the Wiskott--Aldrich syndrome (WAS) family of proteins ([@B49]). The founding members of WAS family proteins, WASp and SCAR/WAVE, function downstream of Rho-family GTPases (Cdc42 and Rac, respectively), where they activate the Arp2/3 complex, resulting in the nucleation of branched actin filaments required for a variety of processes, such as cell migration, endocytosis, exocytosis, and vesicle trafficking ([@B28]; [@B6]; [@B5]). SCAR was recently shown to affect hemocyte developmental migrations, whereas WASp is not required for hemocyte dispersal ([@B11]).

WASH, a more recently identified subclass of the WAS family of proteins, is highly conserved ([@B22]; [@B23]; [@B5]; [@B41]). Wash was first examined in *Drosophila*, where it was shown to function downstream of the Rho1 small GTPase along with the Spire and Cappuccino (formin) actin nucleation factors to control actin and microtubule dynamics during *Drosophila* oogenesis ([@B23]). A similar interaction between mammalian WASH and Rho or Cdc42 has not been observed, although a weak interaction with Rac1 was reported ([@B18]). Similar to other WAS-family proteins, WASH activates actin filament nucleation by the Arp2/3 complex through its conserved C-terminal VCA domain ([@B28]; [@B22]; [@B23]). *Drosophila* and mouse WASH are essential genes that are required many times throughout development ([@B22]; [@B23]; [@B9]; [@B34]; [@B55]; [@B52]). Conditional WASH knockdown in mouse hematopoietic stem cells results in defective blood production associated with anemia and severe cytopenia ([@B56]). Studies in mammalian cell lines and *Dictyostelium* suggest that WASH functions primarily in a multiprotein complex that regulates endosome shape and trafficking in an Arp2/3-dependent manner ([@B7]; [@B13]; [@B10]; [@B15]; [@B31]; [@B34]). This WASH regulatory complex (SHRC; including Strumpellin, SWIP, CCDC53, and FAM21) shares structural features with the SCAR/WAVE regulatory complex (WRC) proteins, as well as some sequence similarity; however the means by which they are activated appears to be different ([@B18]; [@B3]). The SHRC has been shown to regulate endosomal recycling by localizing and polymerizing actin at the surface of mature lysosomes ([@B14]; [@B16]; [@B19]; [@B31]). WASH has also been shown to affect α5β1 integrin recycling, which is necessary for invasive migration ([@B59]). Consistent with this, WASH is up-regulated in invasive breast cancers and a breast cancer cell line ([@B21]; [@B30]; [@B29]).

Here we describe a role for the Rho1 small GTPase and its downstream effector Wash to regulate in an SHRC-independent manner the third stereotypical developmental hemocyte migration, in which posterior hemocytes migrate anteriorly along the ventral midline.

RESULTS
=======

Rho1 is required for the third stereotypical hemocyte developmental migration
-----------------------------------------------------------------------------

Rho1 is expressed in hemocytes ([Figure 1D](#F1){ref-type="fig"}). Expression of a conditional Rho1 biosensor (reporter for active Rho1 expression; Pkn^RBD^--green fluorescent protein (GFP); see *Materials and Methods*) in hemocytes (*Pxn-Gal4; UAS-Pkn^RBD^-GFP*) showed that activated Rho1 protein is not specifically enriched at the leading edge of a migrating hemocyte ([Figure 1C](#F1){ref-type="fig"}).

To examine the role of Rho1 in hemocyte developmental migrations, we performed time-lapse analyses of stage 10--14 embryos expressing UAS-driven GFP under the control of hemocyte-specific Gal4 drivers (*Pxn-Gal4*, *srp.Hemo-Gal4*, or *Crq-Gal4*; [@B2]; [@B48]; [@B53]; [@B12]). We examined *Rho1^1B^* mutant embryos (*Rho1^1B^*; *srp.Hemo-GAL4*, *UAS:GFP*) in which both the hemocytes and tissue through which they migrate are mutant and embryos in which Rho1 was knocked down specifically in the hemocytes using a UAS--RNA interference (RNAi) line for Rho1 (*UAS-Rho1^v12734^; Pxn-GAL4, UAS-GFP*, referred to as *Rho1^RNAi^*; [Figure 1, D--G](#F1){ref-type="fig"}; [@B8]). In both cases, hemocytes were observed to transmigrate properly from the head to the tail ([Figure 1, H and J--L](#F1){ref-type="fig"}). Hemocytes present in the head migrated posteriorly and subsequently underwent lateral migration from the midline to form the three parallel rows of circulating hemocytes ([Figure 1, E--G](#F1){ref-type="fig"}, and Supplemental Video S1). However, whereas hemocytes undergo the first epithelial transmigration to the tail region in *Rho1* mutants, fewer of these tail hemocytes in *Rho1^1B^* (8.2 ± 2.1; *n* = 5) and *Rho1^RNAi^* (6.6 ± 1.6; *n* = 5) migrate anteriorly along the ventral midline than in control embryos (*w*; *Pxn-Gal4, UAS-GFP*; 20.8 ± 3.1, *n* = 5; *p* = 0.0100 and 0.0036, respectively; note that the tail hemocytes present in [Figure 1G](#F1){ref-type="fig"} arrived from the anterior; [Figure 1, E--G′ and I](#F1){ref-type="fig"}). These tail hemocytes in *Rho1*-mutant embryos do not contribute to the circulating hemocytes but instead remain in the tail region. Our results suggest that these tail hemocytes become distinct from the anterior hemocytes: even though they transmigrate and are correctly positioned in the tail in *Rho1* mutants, they appear to have lost their ability to sense and/or respond properly to migratory signals.

Wash is required for the third stereotypical hemocyte developmental migration
-----------------------------------------------------------------------------

WAS-family proteins, through their interactions with Rho-family GTPases, play key roles in the sophisticated regulation of cellular protrusions and membrane trafficking through their tight spatial and temporal coordination of actin dynamics and other cellular machineries ([@B47]; [@B49]; [@B4]). To examine the role of Wash in hemocyte developmental migrations, we performed time-lapse analyses of stage 10--14 embryos in which Wash was depleted specifically in hemocytes using two different UAS-RNAi lines for Wash (*w*; *Pxn-GAL4, UAS-GFP*; *UAS-wash^v24642^*, referred to as *wash^RNAi(2)^*, and *w*; *Pxn-GAL4, UAS-GFP*; *UAS-wash^v39769^*, referred to as *wash^RNAi(3)^*; [Figure 2, A--E](#F2){ref-type="fig"}, and Supplemental Video S2; [@B8]). In both cases, hemocyte transmigration from the head to the tail was similar to control embryos (*w*; *Pxn-Gal4, UAS-GFP*; [Figure 2, D, F, and G](#F2){ref-type="fig"}), consistent with Wash interacting physically with Rho1 ([Figure 2, H and I](#F2){ref-type="fig"}; [@B23]). We performed pull-down experiments using bacterially expressed glutathione *S*-transferase (GST)--Rho-family GTPases and in vitro Wash (SHRC absent) or *Drosophila* embryo lysates (SHRC present). Our results show that Wash interacts directly with GTP-bound Rho1 but not RhoL, Cdc42, or Rac ([Figure 2I](#F2){ref-type="fig"}), regardless of the presence of the WASH regulatory complex. This interaction occurs in vivo, as Wash is immunoprecipitated by Rho1 from whole-cell extracts of 0- to 2-h *Drosophila* embryos ([Figure 2H](#F2){ref-type="fig"}). Similar to Rho1, Wash-depleted hemocytes present in the head migrated posteriorly and underwent the subsequent lateral migration from the midline to form the three parallel lines of circulating hemocytes ([Figure 2, A--B′](#F2){ref-type="fig"}, and Supplemental Video S2). However, Wash knockdown significantly reduces the number of hemocytes that migrate anteriorly from the tail along the ventral midline from 20.8 ± 3.1 (*n* = 5) hemocytes in control embryos to 6.2 ± 2.1 (*n* = 5) and 8.4 ± 1.8 (*n* = 5) hemocytes in *wash^RNAi(2)^* and *wash^RNAi(3)^*, respectively (*p* = 0.0043 and 0.0083, respectively; [Figure 2, A--B′ and E](#F2){ref-type="fig"}, and Supplemental Video S2). As a result, most of the hemocytes present in the tail region in *wash^RNAi(2)^*- and *wash^RNAi(3)^*-mutant embryos have migrated posteriorly from the head. Similar to Rho1, expression of fluorescently tagged Wash (Wash-mChFP; see *Materials and Methods*) does not exhibit specific accumulation at the leading edge in migrating hemocytes ([Figure 2J](#F2){ref-type="fig"}). In contrast to our findings, Wash was reported to play no role in hemocyte dispersal based on analysis of *wash* loss-of-function mutants ([@B11]). Given that *wash* mutants survive until the pupal stage ([@B22]), this difference may be due to perdurance of Wash activity in the *wash* loss-of-function mutants compared with its knockdown in RNAi-treated embryos. Thus our results suggest that each of the hemocyte developmental migrations may require distinct Rho-family GTPase proteins (i.e., RhoL for hemocyte transmigration; Rho1 for tail hemocyte migration).

![Wash participates in a subset of hemocyte developmental migrations. (A--B′) Time-lapse series of ventral surface projections of *wash^RNAi(2)^* (A, A′) and *wash^RNAi(3)^* (B, B′) migrating hemocytes expressing GFP. Hemocytes that began their developmental migrations in the tail were tracked for 180 min (A′, B′). (C) Western analysis of protein extracts from control (*Pxn-Gal4*), *wash^RNAi(2)^*, and *wash^RNAi(3)^* hemocytes probed with antibodies recognizing Wash (α-Wash(P3H3)) and a loading control (α-GFP). The normalized levels of Wash are indicated (with control set to 100). (D, E) Quantification of the number of transmigrated tail hemocytes (D) and number of these tail hemocytes that migrate anteriorly (E) in control (*Pxn-Gal4*), *wash^RNAi(2)^*, and *wash^RNAi(3)^* embryos (*n* ≥ 20). (F, G) Confocal surface projection micrographs (lateral view) of stage 10 *wash^RNAi(2)^* (F) and *wash^RNAi(3)^* (G) embryos stained for DE-cadherin (red) and GFP (green). Transmigrated hemocytes are circled. (H) Western blot of immunoprecipitations (IPs) from *Drosophila* embryo extracts performed with no primary antibody, a nonspecific antibody (9e10), and Rho1 antibody (α-Rho1(P1D9)) and probed with antibodies recognizing Wash (α-Wash(P3H3); arrow). (I) GST pull-down assays with ^35^S-labeled, in vitro--translated, full-length Wash protein (IVT-Wash; top; Wash complex absent) or *Drosophila* embryo extracts (embryo lysate; bottom; Wash complex present) and GST alone or GST-Rho family GTPases loaded with GDP or GTP as indicated. A 5% input is shown. The resulting Western blot of the embryo lysate pull downs (bottom) was probed with antibodies recognizing Wash (α-Wash(P3H3)). (J) Confocal surface projection micrograph of an otherwise wild-type hemocyte expressing a Wash-ChFP fusion protein. All results are given as means ± SEM; *p* values are indicated. Scale bars, 40 μm (A, B, F, G), 10 μm (J).](1665fig2){#F2}

Wash binding to Rho1 maps to the surface-exposed N-terminal KDQ region of Rho1
------------------------------------------------------------------------------

We mapped the Wash-binding domain on Rho1 using deletions and point mutations described previously ([Figure 3](#F3){ref-type="fig"}; [@B27]). We find that Wash binding on Rho1 maps to a surface-exposed region between the phosphate-binding loop and the effector domain of Rho1 (Z fragment; [Figure 3, A and B](#F3){ref-type="fig"}). Wash binding to Rho1 can be greatly reduced by substituting three alanines for the KDQ amino acids (aa 27--29) within this Rho1 domain (referred to as KDQ/AAA) but not by the substitution of nearby residues (F39V or KQVE/AAAA; [Figure 3, A and D](#F3){ref-type="fig"}). Reciprocally, we mapped and identified an N-terminal region of Wash (fragment A; aa 1--124) as the region of Wash required for its binding to Rho1 ([Figure 3, B--D](#F3){ref-type="fig"}).

![Wash interacts directly with Rho1, and mutations that prevent Wash binding to Rho1 disrupt tail hemocyte migration. (A) Schematic of the Rho1 protein, indicating its domains, the fragments used for mapping, and the location of point/substitution mutations. (B) GST pull-down assays with ^35^S-labeled, in vitro--translated, full-length Wash or Wash fragment A (aa 1--124) proteins and GST alone or GST fusions of full-length or fragments of Rho1 GTPase loaded with GTP. A 10% input is shown. The smallest fragment of Rho1 (Z) that interacts with Wash is indicated (arrow). (C) Schematic of the Wash protein, indicating its domains and the position of the Wash A fragment. (D) GST pull-down assays with ^35^S-labeled, in vitro--translated, full-length Wash (Wash FL), Wash fragment A (Wash A), α-catenin, Rok, or p120-catenin proteins and GST alone or GST-Rho1 proteins. The GST-Rho1 proteins were loaded with GDP or GTP as indicated. A 10% input is shown.](1665fig3){#F3}

Mutations that prevent Wash binding to Rho1 disrupt hemocyte migration
----------------------------------------------------------------------

To confirm that Wash is the downstream effector for Rho1 in tail hemocyte migrations, we generated lines expressing a wild-type Rho1 transgene driven by the endogenous Rho1 promoter (*Rho1^1B^* P{*Rho1^WT^*}) or a Rho1 transgene with the KDQ/AAA substitution mutation that disrupts Wash binding (*Rho1^1B^* P{*Rho1^KDQ/AAA^*}) in the background of the *Rho1^1B^*-null mutant such that the only Rho1 activity comes from the transgene ([Figure 4, A--B′](#F4){ref-type="fig"}, Supplemental Figure S1, A--E′′, and Supplemental Video S3; see *Materials and Methods*). The wild-type Rho1 transgene fully rescues the *Rho1^1B^*-mutant phenotype in hemocytes: hemocytes in *Rho1^1B^* P{*Rho1^WT^*} embryos behaved essentially like wild type (21.2 ± 3.0; *n* = 6 posterior hemocytes compared with 20.8 ± 3.1; *n* = 5 for control; [Figure 4, A, A′, D, and E](#F4){ref-type="fig"}). However, hemocytes in *Rho1^1B^* embryos expressing the transgene that disrupts Wash binding (*Rho1^1B^* P{*Rho1^KDQ/AAA^*}) exhibited tail hemocyte migration defects similar to those in *wash* and *Rho1* mutants ([Figure 4, B, B′, D, and E](#F4){ref-type="fig"}). Hemocytes present in the head in *Rho1^1B^* P{*Rho1^KDQ/AAA^*} embryos migrated posteriorly and underwent subsequent lateral migrations from the midline to form the three parallel lines of circulating hemocytes ([Figure 4B](#F4){ref-type="fig"} and Supplemental Video S3). However, similar to that observed with Rho1 and Wash knockdown, there is significant reduction in the number of hemocytes that migrate anteriorly from the tail along the ventral midline (21.2 ± 3.0 \[*n* = 6\] hemocytes in control \[*Rho1^1B^* P{*Rho1^WT^*}\] embryos compared with 3.2 ± 1.8 \[*n* = 5\] hemocytes in *Rho1^1B^* P{*Rho1^KDQ/AAA^*}; *p* = 0.0011; [Figure 4, B, B′, D, and E](#F4){ref-type="fig"}, and Supplemental Video S3).

![Mutations that prevent Wash binding to Rho1 disrupt hemocyte migration. (A--C′) Time-lapse series of ventral surface projections of migrating hemocytes expressing GFP in *Rho1^1B^* P{*Rho1^WT^*} (A), *Rho1^1B^* P{*Rho1^KDQ/A^*} (B), and *Rho1^1B^* P{*Rho1^F39V^*} (C) embryos. Hemocytes that began their developmental migrations in the tail were tracked for 180 min (A′, B′, C′). (D, E) Quantification of the number of transmigrated tail hemocytes (D) and number of these tail hemocytes that migrate anteriorly (E) in control (*Pxn-Gal4*), *Rho1^1B^* P{*Rho1^WT^*}, *Rho1^1B^* P{*Rho1^KDQ/A^*}, *Rho1^1B^* P{*Rho1^F39V^*}*, α-catenin^RNAi(2)^* and *α-catenin^RNAi(3)^* embryos (*n* ≥ 20). (F, F\') Time-lapse series of ventral surface projections of migrating hemocytes expressing GFP in an *α-catenin^RNAi(2)^* embryo. Hemocytes that began their developmental migrations in the tail were tracked for 180\'. All results are given as means ± SEM; *p* values are indicated. Scale bars, 40 μm (A--C\', F, F\').](1665fig4){#F4}

As a specificity control, we examined another, nearby substitution mutation in Rho1\'s effector domain (F39V), which does not affect Wash binding ([Figure 3, A and D](#F3){ref-type="fig"}, Supplemental Figure S1, E--E′′, and Supplemental Video S3). We generated a transgenic line expressing a Rho1 transgene with the F39V point mutation in the background of the *Rho1^1B^*-null mutant (*Rho1^1B^* P{*Rho1^F39V^*}) and found that all hemocyte developmental migrations are indistinguishable from control embryos (*Rho1^1B^* P{*Rho1^WT^*}; [Figure 4, C, C′, D, and E](#F4){ref-type="fig"}). Our results indicate that proper tail hemocyte developmental migration is dependent on a Rho1/Wash interaction.

Of interest, we previously identified the Rho1 KDQ region as the region required for Rho1 binding to α-catenin ([Figure 3, A and D](#F3){ref-type="fig"}; [@B27]). However, using time-lapse video analyses of stage 10--14 embryos in which α-catenin was depleted specifically in hemocytes using two different UAS-RNAi lines for α-catenin (*w*; *Pxn-GAL4, UAS-GFP*; *UAS-α-catenin^KK107916^*, referred to as α-catenin^RNAi(2)^, and y^1^ sc\* v^1^; P{TRiP.HMS00317}attP2, referred to as α-catenin^RNAi(3)^), we find that α-catenin is not required for the third stereotypical hemocyte developmental migration (19.0 ± 1.4 \[*n* = 6\] migrating tail hemocytes in α-catenin^RNAi(2)^ embryos and 19.6 ± 0.2 \[*n* = 5\] migrating tail hemocytes in α-catenin^RNAi(3)^ embryos, compared with 20.8 ± 3.1 \[*n* = 5\] in control embryos; *p* = 0.1439; [Figure 4, F, F′, D and E](#F4){ref-type="fig"}, Supplemental Figure S1, F and G, and Supplemental Video S3; [@B8]). Thus, despite the ability of Rho1 to bind two downstream effectors through its KDQ region, it is the binding to Wash that is relevant in the context of hemocyte developmental migrations, indicating that Rho-family GTPases have context-dependent specificity for their effector choices.

Knockdown of WASH regulatory complex subunits does not affect hemocyte developmental migrations
-----------------------------------------------------------------------------------------------

Mammalian WASH has been shown to function as part of a multiprotein complex (SHRC; [@B18]; [@B3]). Although *Drosophila* has orthologues of the SHRC proteins, whether WASH always functions as part of this SHRC complex is not known. WASH, as part of the SHRC, has been proposed to regulate the recycling of receptors and other proteins via its regulation of intracellular vesicle trafficking ([@B31]). To determine whether endosome recycling of receptors/factors/components was required for the Rho1\>Wash--mediated tail hemocyte migrations, we performed time-lapse video analyses of stage 10--14 embryos in which the SHRC members *SWIP*/*CG13957*, *Strumpellin*/*CG12272*, and *CCDC53/CG7429* were depleted specifically in hemocytes using UAS-RNAi lines (*w*; *Pxn-GAL4*, *UAS-GFP*; *UAS-CG13957/SWIP^v105966^*, referred to as *SWIP^RNAi^*; *w*; *Pxn-GAL4, UAS-GFP*; *UAS-Strumpellin^v107954^*, referred to as *Strumpellin^RNAi^*; and *w*; *Pxn-GAL4, UAS-GFP*; *UAS-CCDC53^v110316^*, referred to as *CCDC53^RNAi^*; [@B8]). Of interest, we find that all hemocyte developmental migrations in SHRC-knockdown hemocytes are indistinguishable from wild-type embryos ([Figure 5, A--E](#F5){ref-type="fig"}, Supplemental Figure S1, H--J, and Supplemental Video S4). In particular, knockdown of SHRC members does not significantly reduce the number of posterior hemocytes that transmigrate to the tail or that migrate anteriorly from the tail along the ventral midline (17.2 ± 1.6 \[*n* = 10 in *SWIP^RNAi^* embryos, 22.0 ± 2.2 \[*n* = 5\] in *Strumpellin^RNAi^* embryos, and 19.0 ± 0.9 \[*n* = 5\] in *CCDC53^RNAi^* embryos, compared with 20.8 ± 3.1 \[*n* = 5\] in control embryos; [Figure 5, D and E](#F5){ref-type="fig"}). Thus our results reveal an SHRC-independent role for Wash in regulating tail hemocyte migration.

![Wash functions through the Arp2/3 complex, but not the WASH regulatory complex, for tail hemocyte migration. (A--C′) Time-lapse series of ventral surface projections of migrating hemocytes expressing GFP in *SWIP^RNAi^* (A), *Strumpellin^RNAi^* (B), or *CCDC53^RNAi^* (C) embryos. Hemocytes that began their developmental migrations in the tail were tracked for 180 min (A′, B′, C′). (D, E) Quantification of the number of transmigrated tail hemocytes (D) and number of these tail hemocytes that migrate anteriorly (E) in control (*Pxn-Gal4*), *SWIP^RNAi^, Strumpellin^RNAi^*, *CCDC53^RNAi^*, and *Arp3^RNAi^* embryos (*n* ≥ 20). (F, F′) Time-lapse series of ventral surface projections of migrating hemocytes expressing GFP in *Arp3^RNAi^* embryos. Hemocytes that began their developmental migrations in the tail were tracked for 180 min (F′). All results are given as means ± SEM; *p* values are indicated. Scale bars, 40 μm (A--C′, F, F′).](1665fig5){#F5}

Knockdown of Arp2/3 function mimics Wash\'s affects on hemocyte migrations
--------------------------------------------------------------------------

Polymerization of actin filaments against cellular membranes provides the driving force for cellular processes such as migration and endocytosis ([@B28]; [@B49]; [@B5]). Mutations specifically disrupting Wash\'s actin nucleation activity do not exist; however, Wash\'s actin nucleation activity is dependent on its interaction with the Arp2/3 complex ([@B22]; [@B23]). We performed time-lapse video analyses of stage 10--14 embryos in which Arp3 (Arp2/3 complex subunit) was knocked down specifically in hemocytes (*w*; *UAS-Arp3^v36520^*; *Pxn-GAL4, UAS-GFP* referred to as *Arp3^RNAi^*; [Figure 5, D--F′](#F5){ref-type="fig"}, Supplemental Figure S1K, and Supplemental Video S4; [@B8]). Similar to Wash knockdown, hemocytes transmigrated properly from the head to the tail in *Arp3^RNAi^*-knockdown embryos, and fewer of these tail hemocytes migrated anteriorly from the tail (6.2 ± 1.7 \[*n* = 5\] compared with 20.8 ± 3.1 \[*n* = 5\] in control embryos; p = 0.0031; [Figure 5, D and E](#F5){ref-type="fig"}), suggesting that Wash\'s actin nucleation activity is required for this migration. *Arp3^RNAi^*-knockdown hemocytes are also less organized, resulting in the simultaneous formation of three lines of hemocytes migrating posteriorly from the head rather than the lateral movement of hemocytes from the ventral midline observed in control embryos ([Figure 5, F and F′](#F5){ref-type="fig"}, and Supplemental Video S4), consistent with the Arp2/3 complex functioning downstream of other WAS family proteins as well ([@B11]).

Cellular protrusions are severely reduced in Rho1\>Wash\>Arp2/3, but not SHRC, posterior hemocytes
--------------------------------------------------------------------------------------------------

Wash, through activation of the Arp2/3 complex, mediates branched actin nucleation required for cellular processes, including lamellipodial formation and endocytosis/exocytosis. Because active cell migration requires dynamic cellular protrusions (lamellipodia and filopodia), we examined cell protrusions in Rho1, Wash, and Arp3 anterior and posterior hemocytes, as well as those in SHRC subunits ([Figure 6, A--N](#F6){ref-type="fig"}). Hemocyte cell body size (both anterior and posterior) was not significantly different in any of the knockdown mutants compared with those in control hemocytes, except for CCDC53, which showed a modest increase in size due to the presence of enlarged vacuoles ([Figure 6, O and P](#F6){ref-type="fig"}). Strikingly, posterior hemocytes in *Rho1^RNAi^*-, *wash^RNAi(2)^*-, and *Arp3^RNAi^*-knockdown embryos, but not those knocked down for SHRC subunits, exhibit severe reduction in cellular protrusion area, consistent with their lack of migration (219.8 ± 14.2 μm^2^ for control \[*n* = 22\] compared with 39.1 ± 4.4 μm^2^ for *Rho1^RNAi^* \[*p* \< 0.0001, *n* = 27\], 36.0 ± 7.3 μm^2^ for *wash^RNAi(2)^* \[*p* \< 0.0001, *n* = 20\], 35.5 ± 3.4 μm^2^ for *Arp3^RNAi^* \[*p* \< 0.0001, *n* = 32\], 162.1 ± 15.2 μm^2^ for *Strumpellin^RNAi^* \[*p* = 0.0090, *n* = 27\], 169.3 ± 13.2 μm^2^ for *SWIP^RNAi^* \[*p* = 0.0123, *n* = 23\], and 187.8 ± 14.0 μm^2^ for *CCDC53^RNAi^* \[*p* = 0.1181, *n* = 26\]; [Figure 6, B, D, F, H, J, L, N, and R](#F6){ref-type="fig"}). Although *Strumpellin^RNAi^*, *SWIP^RNAi^*, and *CCDC53^RNAi^* posterior hemocytes show a modest decrease in protrusion area, it is unlikely to be a major player, as the area of protrusions in *wash^RNAi(2)^* compared with the SHRC subunits is also significantly different (*p* \< 0.0001 for each; [Figure 6R](#F6){ref-type="fig"}). Of interest, *Rho1^RNAi^*, *wash^RNAi(2)^*, and *Arp3^RNAi^* anterior hemocytes, but not those in SHRC subunits, also show a moderate reduction in cellular protrusion area that is not sufficient to prevent their developmental migration (239.2 ± 27.9 μm^2^ for control \[*n* = 35\] compared with 78.3 ± 8.0 μm^2^ for *Rho1^RNAi^* \[*p* \< 0.0001, *n* = 31\], 133.8 ± 14.8 μm^2^ for *wash^RNAi(2)^* \[*p* = 0.0016, *n* = 26\], 124.3 ± 10.0 μm^2^ for *Arp3^RNAi^* \[*p* = 0.0004, *n* = 32\], 262.2 ± 29.4 μm^2^ for *Strumpellin^RNAi^* \[*p* = 0.5834, *n* = 24\], 212.3 ± 16.6 μm^2^ for *SWIP^RNAi^* \[*p* = 0.4107, *n* = 27\], and 217.6 ± 18.5 μm^2^ for *CCDC53^RNAi^* \[*p* = 0.5349, *n* = 30\]; [Figure 6Q](#F6){ref-type="fig"}).

![Cellular protrusions are severely reduced in Rho1\>Wash\>Arp2/3, but not SHRC, posterior hemocytes. (A--N) Confocal projections of anterior (A, C, E, G, I, K) or posterior (B, D, F, H, J, L) hemocytes in equivalently staged embryos expressing GFP in control (A, B), *Rho1^RNAi^* (C, D), *wash^RNAi(2)^* (E, F), *Arp3^RNAi^* (G, H), *Strumpellin^RNAi^* (I, J), *SWIP^RNAi^* (K, L), and *CCDC53^RNAi^* (M, N) backgrounds. Scale bars, 10 μm (A--N). (O--T) Quantification of hemocyte cell body size (O, P), protrusion area (Q, R), and number of vacuoles (S, T) in anterior (O, Q, S) or posterior (P, R, T) hemocytes from control or *Rho1^RNAi^, wash^RNAi(2)^, Arp3^RNAi^, Strumpellin^RNAi^, SWIP^RNAi^*, and *CCDC53^RNAi^* embryos at the onset of posterior to anterior migration. All results are given as means ± SEM; *p* values are indicated.](1665fig6){#F6}

In examining Rho1\>Wash\>Arp2/3 hemocytes, the number of vacuoles present in both the anterior and posterior hemocyte cell bodies was prominent in comparison to control hemocytes (anterior hemocytes: 3.7 ± 0.2 for control \[*n* = 24\] compared with 8.7 ± 0.2 for *Rho1^RNAi^* \[*p* \< 0.0001, *n* = 51\], 8.2 ± 0.4 for *wash^RNAi\[2\]^* \[*p* \< 0.0001, *n* = 29\], and 9.2 ± 0.3 for *Arp3^RNAi^* \[*p* \< 0.0001, *n* = 43\]; and posterior hemocytes: 3.5 ± 0.1 for control \[*n* = 30\] compared with 8.7 ± 0.2 for *Rho1^RNAi^* \[*p* \< 0.0001, *n* = 49\], 8.5 ± 0.3 for *wash^RNAi\[2\]^* \[*p* \< 0.0001, *n* = 29\], and 9.5 ± 0.3 for *Arp3^RNAi^* \[*p* \< 0.0001, *n* = 31\]; [Figure 6, S and T](#F6){ref-type="fig"}). Hemocytes knocked down for SHRC subunits have a less prominent but significant effect on the number of anterior (3.7 ± 0.2 for control compared with 5.6 ± 0.3 for *Strumpellin^RNAi^* \[*p* \< 0.0001, *n* = 31\], 6.8 ± 0.3 for *SWIP^RNAi^* \[*p* \< 0.0001, *n* = 38\], and 7.8 ± 0.3 for *CCDC53^RNAi^* \[*p* \< 0.0001, *n* = 38\]); and posterior (3.5 ± 0.1 for control compared with 6.1 ± 0.4 for *Strumpellin^RNAi^* \[*p* \< 0.0001, *n* = 30\], 6.9 ± 0.3 for *SWIP^RNAi^* \[*p* \< 0.0001, *n* = 41\], and 7.9 ± 0.3 for *CCDC53^RNAi^* \[*p* \< 0.0001, *n* = 42\]) hemocyte vacuoles ([Figure 6, S and T](#F6){ref-type="fig"}). This increased number of vacuoles in Wash and SHRC subunits likely reflects a separate, SHRC-dependent role for Wash in hemocytes and is consistent with previously proposed roles for WASH in endocytosis and/or exocytosis.

DISCUSSION
==========

Guided cell migrations, essential for normal development and maintenance functions of animal body plans and organ systems, require tight spatial and temporal coordination of cytoskeleton and cytoskeleton--membrane interactions. We find that the Rho1 small GTPase, through its downstream effector Wash, regulates one of the four hemocyte stereotypical developmental migrations in which posterior tail hemocytes migrate anteriorly along the ventral midline. Wash activates the Arp2/3 complex, whose activity is needed for this migration, whereas members of the SHRC (SWIP/CG13957, Strumpellin/CG12272, and CCDC53/CG7429) are not. Mapping of the interaction domain of Wash with Rho1 shows that Rho1 uses the same surface-exposed region to interact with either Wash or α-catenin. Despite this overlap, Rho1 uses Wash, not α-catenin, as its downstream effector for this function, even though α-catenin is present in hemocytes, indicating that Rho-family GTPases have context-dependent specificity for their effector choices.

WASP is known to function downstream of and bind directly to the Cdc42 small GTPase, whereas SCAR/WAVE proteins function as part of a larger multimeric complex (WRC) and associate indirectly with the Rac small GTPase ([@B49]). The situation with Wash is not yet clear. Similar to SCAR, mammalian WASH has been shown to function as part of a multiprotein complex (SHRC; [@B18]; [@B3]). No interaction (direct or indirect) has been observed between mammalian WASH and Rho or Cdc42, although a weak interaction with Rac1 was reported ([@B18]). In contrast, the *Drosophila* Wash protein has been shown to bind directly to Rho1 but not to Rac, Cdc42, or RhoL ([@B23]; this study). Although SHRC proteins are present and form a complex in *Drosophila*, we find that they are not required for posterior hemocyte developmental migrations. Thus our results reveal an SHRC-independent role for Wash in regulating tail hemocyte migration. Wash and the SHRC subunits exhibit an increased number of vacuoles in both anterior and posterior hemocyte cell bodies, consistent with a separate, SHRC-dependent, role for Wash in hemocytes. Taken together, our results suggest that Wash can exist as part of a multiprotein complex like the SCAR/WAVE proteins and function independently of such a complex (similar to WASP) in a context-dependent manner. At least in *Drosophila*, when Wash functions separately from other SHRC proteins, it does so by binding directly to and functioning downstream of the Rho1 small GTPase. It is also possible that because there are more WAS family members in mammals than in flies, each fly protein might have functions that overlap with multiple mammalian proteins. In the future, it will be interesting to see how Wash chooses its context-dependent means of action.

During migration, Rho\'s established role is to work at the posterior of a cell to retract the tail through myosin contractility ([@B43]). However, other studies show that active Rho can also function at the leading edge of migrating cells, where it promotes membrane ruffling and facilitates cell motility ([@B20]; [@B25]). The Rho1\>Wash\>Arp2/3 pathway in hemocyte migrations could be functioning to induce the formation of branched actin networks in the leading edge of cells necessary for migration or provide a framework for organizing receptors at the cell surface into clusters to facilitate sorting and/or signaling. Consistent with this possibility, Rho1\>Wash\>Arp2/3 posterior hemocytes exhibit severely reduced protrusion areas and fail to migrate anteriorly. Alternatively, the Rho1\>Wash\>Arp2/3 pathway could be activated on the surface of endosomes near the leading edge, which is important for receptor recycling and/or signaling. A new actin-dependent mechanism of long-range vesicle transport was reported that relies on the recruitment of the linear nucleation promotion factors formin-2 and Spire1/2 to assemble an extensive actin meshwork on the surface of vesicles ([@B33]). Given that *Drosophila* Wash was shown to interact with Capu (formin) and Spire ([@B23]), it could be functioning in signal transduction and/or recycling through such a mechanism independent of the SHRC. Indeed, *Rickettsia* has been shown to use two independent actin polymerization mechanisms for its motility, one requiring activation of the Arp2/3 complex, and one requiring Sca2, a mimic of host formins ([@B36]). Consistent with these possibilities, tail hemocytes appear to have lost their ability to sense and/or respond to developmental signals or are unable to receive additional signals not required by anterior hemocytes.

A pattern is emerging in which distinct Rho-family GTPases are required to regulate each of the stereotyped *Drosophila* hemocyte migrations, often through a WAS-family protein. RhoL has been shown to function during the first developmental migration, in which a subset of head hemocytes undergoes an invasive transmigration to populate the posterior tail region of the embryo ([@B42]). In addition, the WAS family member SCAR is required for hemocyte motility ([@B11]) and affects the ability of the midline hemocytes, which migrate laterally to generate three rows of circulating hemocytes. SCAR requires its SCAR/WAVE (Hem/Kette/Nap1) complex ([@B11]), which usually functions downstream of the Rac small GTPase ([@B49]). A requirement for Rac in hemocyte developmental migrations has not yet been reported. Our data demonstrate that Rho1, through its effector Wash, regulates the third stereotyped migration in an Arp2/3-dependent manner. Thus hemocyte developmental migrations provide a superb model in which to systematically study Rho GTPases and explore their interactions with WAS-family proteins.

MATERIALS AND METHODS
=====================

Fly strains and genetics
------------------------

Flies were cultured and crossed on yeast/cornmeal/molasses/malt extract medium and maintained at 25°C. The following alleles were used: *Rho1^1B^* ([@B26]) and *Rho1^1B^* P{*Rho1^WT^*}, *Rho1^1B^* P{*Rho1^KDQ/AAA^*}, and *Rho1^1B^* P{*Rho1^F39V^*} (this study). The following UAS-driven RNAi stocks from the Vienna *Drosophila* Resource Center Stock Center (Vienna, Austria) were used: *w^1118^;* P{*GD4726*}v12734*/CyO* (*Rho1^RNAi^*); *w^1118^;* P{*GD932*}v24642 (*wash^RNAi(2)^*); *w^1118^;* P{*GD7950*}v39769 (*wash^RNAi(3)^*); P{*KK111410*}VIE-260B (*Arp3^RNAi^*); P{*KK108277*}VIE-260B (*Arpc1^RNAi^*); P{*KK107916*}VIE-260B (α-catenin^RNAi(2)^); P{*KK101329*}VIE-260B (*SWIP^RNAi^*); P{*KK101498*}VIE-260B (*Strumpellin^RNAi^*); and P{*KK100545*}VIE-260B (*CCDC53^RNAi^*; [@B8]). The following TRiP line was used: y^1^ sc\* v^1^; P{TRiP.HMS00317}attP2 (α-catenin^RNAi(3)^; Bloomington Stock Center, Bloomington, IN). Hemocyte-specific drivers used were *y^1^ w\**; P{*crq-GAL4*}2 (Bloomington Stock Center); P{*Pxn-GAL4*}II, P{*UAS-GFP*}II; P{*Pxn-GAL4*}III, P{*UAS-GFP*}III ([@B48]); and P{*srp.Hemo-Gal4*}III, P{*UAS-GFP*}III ([@B51]). The following UAS-driven, fluorescently tagged reporter lines were used: P{*UAS-Pkn^RBD^-GFP*}27, P{*UAS-mRFP-actin*}13, and P{*UAS-Wash-ChFP*}30 (this study).

Generation of GFP/cherry fluorescent protein fusion constructs and transgenics
------------------------------------------------------------------------------

UAS-Wash--cherry fluorescent protein (ChFP) was made by fusing ChFP ([@B60]) N-terminal to the ATG of the full-length Wash open reading frame and subsequently cloned as a *Kpn*I--*Nhe*I fragment into the *Kpn*I--*Xba*I sites of the pUASp vector ([@B39]). UAS-Pkn^RBD^-GFP was made by fusing amino acids 1--339 of the Rho1 downstream effector PKN containing a G58A point mutation ([@B24]) N-terminal of GFP and subsequently cloned as a *Kpn*I--*Not*I fragment into the *Kpn*I--*Not*I sites of the pUASp vector. These constructs were used to make germline transformants as previously described ([@B44]). The resulting transgenic lines (P{*w+*; *UAS-ChFP-Wash*}20 and P{*w+*; *UAS-Pkn^RBD^-GFP*}27) were mapped to a single chromosome and shown to have nonlethal insertions.

Generation of *Rho1^1B^ P{Rho1^WT^}* and Rho1 point mutation constructs and transgenics
---------------------------------------------------------------------------------------

A ∼7-kb *Hin*dIII--*Mlu*I genomic fragment encompassing the entire Rho1 gene was subcloned into the Casper transformation vector ([@B35]). The intronic regions were then removed by substituting wild-type cDNA sequence (*Rho1^WT^*) or the cDNA with point mutations generated by PCR (*Rho1^KDQ/AAA^*: KDQ to AAA; *Rho1^F39V^*: F39 to V; and *Rho1^KQVE/AAAA^*: KQVE to AAAA) for the genomic sequence between the ATG and stop codons. These constructs were used to make germline transformants as previously described ([@B44]). Transgenic lines that mapped to chromosome 2 and that had nonlethal insertions were kept. The resulting transgenic lines (P{*w+*; *Rho1^WT^*}, P{*w+*; *Rho1^KDQ/AAA^*}, P{*w+*; *Rho1^F39V^*}, and P{*w+*; *Rho1^KQVE/AAAA^*}) were recombined onto the *Rho1^1B^*-null chromosome to assess the contribution of the particular Rho1 transgene. The resulting recombinants are essentially gene replacements, as *Rho1* activity is only provided by the transgene. These transgenes rely not on overexpression, but on the spatial and temporal expression driven by the endogenous *Rho1* promoter itself. We analyzed a minimum of three lines per construct and checked all lines to confirm that the levels and spatial distribution of their expression is indistinguishable from wild type. The wild-type version of this transgene fully rescues the maternal and zygotic phenotypes of the *Rho1^1B^* loss-of-function mutation.

Confocal image acquisition
--------------------------

Appropriately staged embryos were fixed, stained, and mounted onto glass slides according to standard procedures ([@B1]). The following primary antibodies were used to stain the embryos: rabbit anti-GFP (1:125; Molecular Probes/Invitrogen, Rockford, IL) and rat anti-DCad2 (1:100; Developmental Studies Hybridoma Bank, Iowa City, IA). The secondary antisera used were donkey anti-rabbit Alexa 488 and donkey anti-rat Alexa 568 (1:1000; Molecular Probes/Invitrogen). Confocal microscopy was performed using a Zeiss LSM-510M or Zeiss LSM-780 microscope (Carl Zeiss, Jena, Germany) with excitation at 488 or 543 nm and emission collection with BP-500-550 or LP560 filter, respectively. A Plan-Apochromat 20×/0.75 dry objective or a Plan-NeoFluor 40×/1.3 oil objective was used for imaging. A 30-μm length of the embryo periphery was imaged in 1.5-μm steps. Images were processed in ImageJ (National Institutes of Health, Bethesda, MD) and assembled with Canvas 8 software (Deneva Systems).

Live image acquisition
----------------------

For transmigration studies, embryos were collected on grape agar plates at 25°C for 1 h and then aged at 25°C for 7 h. The transmigrated hemocytes were counted halfway through germ-band retraction. For migration studies, embryos were collected on grape agar plates at either 1) 25°C for 1 h and then aged at 18°C for 16 h (developmental studies) or 20 h (reporter studies), or 2) at 29°C for 1 h and then aged at 29°C for 6.5 h (developmental studies). The two regimens yielded indistinguishable results. Embryos were then dechorionated, dried for 5 min, transferred onto strips of glue dried onto No. 1.5 coverslips, and covered with series 700 halocarbon oil (Halocarbon Products, River Edge, NJ). For developmental studies, 24-μm stacks were taken once per minute with a 0.4-μm step size over the course of 3 h. For reporter studies, 15-μm stacks were taken once per minute with a 0.25-μm step size over the course of 1 h.

The following microscopes were used for reporter and some developmental studies: 1) an UltraVIEW VoX Confocal Imaging System (PerkinElmer, Waltham, MA) in a Nikon Eclipse Ti stand (Nikon Instruments, Melville, NY) with 60×/1.4 numerical aperture (NA), 20×/0.75 NA, or 40×/1.3 NA objective lens and controlled by Volocity software, version 5.3.0 (PerkinElmer). Images were acquired at 491 and 561 nm with a Yokogawa CSU-X1 confocal spinning disk head equipped with a Hamamatsu C9100-13 electron-multiplying charge-coupled device (EMCCD) camera (PerkinElmer), and 2) a Nikon LiveScan Swept Field Confocal (for Nikon by Prairie Technologies, Middleton, WI) mounted on a Nikon Eclipse Ti with 20×/0.45 NA objectives lens, using the NIS-Elements AR 3.0 as acquisition software (Nikon Instruments). Images were acquired with a 491-nm laser, and a Photometrics QuantEM 512SC EMCCD camera (Photometrics, Tucson, AZ).

Image analysis
--------------

Images were acquired on Nikon Live, Volocity, or Zeiss LSM software and exported as tiffs. Maximum intensity *xy*-projections of 24 μm (developmental migration) or 1--10 μm (reporter and fixed tissue studies) were generated. Hemoctyes were counted, tracked, and outlined in ImageJ using the base package and Manual Tracking plug-in (<http://rsbweb.nih.gov/ij/plugins/>).

Western blots
-------------

Hemocytes were recovered from larvae as described ([@B46]). The resulting hemocytes were mixed with lysis buffer (50 mM Tris, pH 7.8, 150 mM NaCl, 1% NP-40), flash frozen in liquid nitrogen, and stored at −80°C. Samples were normalized to a loading control (GFP; Gro) and blotted using standard procedures. The following antibodies were used: anti-Rho1 (P1D9; 1:50; [@B27]); anti-Wash mouse polyclonal (1:200; P3H3; [@B23]; [@B37]); anti-Arp3 (1:50; [@B45]); anti-GFP (1:1000; Sigma-Aldrich, St. Louis, MO); anti-SWIP/CG13957 (1:400; this study); anti-Strumpellin/CG12272 (1:200; this study); anti-CCDC53/CG7429 (1:200; this study); goat anti-rabbit Alexa 568 (1:15,000; Invitrogen); donkey anti-mouse horseradish peroxidase (1:15,000; Molecular Probes), and, from the Developmental Studies Hybridoma Bank, anti-Groucho (1:300; Gro) and anti--α-catenin (1:10; DCAT-1).

Antibody generation
-------------------

Polyclonal antiserum against the *Drosophila* WASH regulatory complex subunits Strumpellin, SWIP, CCDC53, and FAM21 were generated by immunizing Balb/c BYJ Rb(8.12) 5BNR/J mice (strain 1802; Jackson Labs, Bar Harbor, ME) with a mixture of two proteins each that comprised GST fused to their N-terminal or C-terminal halves, except for CCDC53 (CG7429), which was the full-length protein (aa 1--177) fused to GST. *Drosophila* Strumpellin (CG12272): N-terminal (aa 1--618) or C-terminal (aa 618--1192). *Drosophila* SWIP (CG13957): N-terminal (aa 1--566) or C-terminal (aa 566--1103). FAM21 (CG16742): N-terminal (aa 1--830) or C-terminal (aa 830--1470).

Immunoprecipitations and pull-down assays
-----------------------------------------

GST-Rho1 wild-type and point mutations were previously described ([@B27]). Wash constructs were described previously ([@B29]). Protein expression, in vitro translations, immunoprecipitations, and GST pull-down assays were performed as previously described ([@B27]; [@B26]; [@B40]). *Drosophila* wild-type 0- to h embryo whole-cell extract was a gift from T. Tsukiyama (Fred Hutchinson Cancer Research Center, Seattle, WA).

Statistical analyses
--------------------

Prism graphing software was used to organize data, generate graphs, and perform statistical analysis. In all cases, the mean was graphed with error bars representing ±SEM. Statistical analysis was performed using an unpaired *t* test, with Welch\'s correction in cases in which variance between data sets was significantly different. *p* \< 0.05 was considered significant.
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GFP

:   green fluorescent protein

GST

:   glutathione *S*-transferase

mCHFP

:   mCherry fluorescent protein

PVR

:   platelet-derived growth factor/endothelial growth factor-receptor-related

SHRC

:   WASH regulatory complex

WAS

:   Wiskott Aldrich syndrome

WRC

:   WAVE regulatory complex.
